LLY compared with TNGX: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

TNGXTango Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

TNGXTango Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

Q1 FY26±5.3%▲+9.80%×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

TNGX

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±11.4%▼−4.81%×0.42

May 14 '26±14.3%▼−2.51%×0.17

= impliedLLY realized, solidTNGX realized, hatchedOne scale, both sides: full bar = 43%× = |realized| ÷ impliedSource: market data

Q1 FY26

±42.5%

▲+36.28%

×0.85

Jan 8 '26±30.3%▼−6.23%×0.20

LLYELI Lilly & Co

1,360.90▼−0.28%· post 1,358.90

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

TNGXTango Therapeutics, Inc.

21.49▲+2.96%· post 21.49

ClosedNov 6 '26

Mkt cap$3.6BRevenue$54MQ3 FY25Revenue$42MFY24

Compare

ClosedNov 6 '26

LLYELI Lilly & Co

TNGXTango Therapeutics, Inc.

1,360.90▼−0.28%post 1,358.90

Price

21.49▲+2.96%post 21.49

$1.2T

Mkt cap

$3.6B

Q3 FY26$24.4B

Revenue

$54MQ3 FY25

FY25$65.2B

Revenue

$42MFY24

LLY1,360.90▼−0.28%vsTNGX21.49▲+2.96%ClosedNov 6 '26